RESEARCHER PROFILE
Robin Dawn Clark
← Back to Loma Linda University
R
Loma Linda University
Robin Dawn Clark works in Genomics and Rare Diseases, Advanced Synthetic Organic Chemistry, Receptor Mechanisms and Signaling, Organic Chemistry Synthesis Methods, Synthesis and biological activity. Recorded institutional associations include Flinders University, Loma Linda University, Loma Linda University Children's Hospital.
330Publications
8,077Citations
46H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies
2009 · 399 citationsMicroduplication 22q11.2, an Emerging Syndrome: Clinical, Cytogenetic, and Molecular Analysis of Thirteen Patients
2003 · 382 citationsA Drosophila Genetic Resource of Mutants to Study Mechanisms Underlying Human Genetic Diseases
2014 · 381 citationsClinical delineation and natural history of the PIK3CA ‐related overgrowth spectrum
2014 · 305 citationsDisruption of an EHMT1-Associated Chromatin-Modification Module Causes Intellectual Disability
2012 · 269 citationsThe phenotype of 45,X/46,XY mosaicism: an analysis of 92 prenatally diagnosed cases.
1990 · 219 citationsA recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome
2007 · 200 citationsRare Missense and Synonymous Variants in UBE1 Are Associated with X-Linked Infantile Spinal Muscular Atrophy
2008 · 186 citationsExome Sequencing and Functional Validation in Zebrafish Identify GTDC2 Mutations as a Cause of Walker-Warburg Syndrome
2012 · 185 citationsThe interaction of RS 25259‐197, a potent and selective antagonist, with 5‐HT3 receptors, in vitro
1995 · 168 citationsMutations in LTBP4 Cause a Syndrome of Impaired Pulmonary, Gastrointestinal, Genitourinary, Musculoskeletal, and Dermal Development
2009 · 165 citationsDetection of mosaicRB1mutations in families with retinoblastoma
2009 · 160 citationsOverlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP–HHT syndrome
2010 · 147 citationsThe Leimgruber-Batcho Indole Synthesis
1984 · 133 citationsProteus syndrome: An expanded phenotype
1987 · 122 citationsThe Effects of Novel, Selective 5-Hydroxytryptamine (5-HT) 4 Receptor Ligands in Rat Spatial Navigation
1997 · 112 citationsA dyadic approach to the delineation of diagnostic entities in clinical genomics
2021 · 112 citationsMutations in ANKLE2, a ZIKA Virus Target, Disrupt an Asymmetric Cell Division Pathway in Drosophila Neuroblasts to Cause Microcephaly
2019 · 110 citations2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists
1993 · 108 citationsPreparation and reactions of .beta.-chloro-.alpha.,.beta.-unsaturated ketones
1976 · 106 citationsPharmacological characterization of two novel and potent 5‐HT4receptor agonists, RS 67333 and RS 67506,in vitroandin vivo
1995 · 101 citationsSynthesis of a cytotoxic vernolepin prototype. Ozonization of silyloxyalkenes
1976 · 99 citationsChemInform Abstract: THE LEIMGRUBER‐BATCHO INDOLE SYNTHESIS
1984 · 93 citationsNovel mutations in PAX6, OTX2 and NDP in anophthalmia, microphthalmia and coloboma
2015 · 89 citationsRecurrent CNVs and SNVs at the NPHP1 Locus Contribute Pathogenic Alleles to Bardet-Biedl Syndrome
2014 · 85 citations
